CClaimWatch
Claims closedsecurities

Taro Pharmaceutical Industries Ltd. Securities Litigation

Up to $2.53

This settlement is closed to new claims — the deadline was August 16, 2024. You can still see what it was about and follow the case in court below. Looking for money you can still claim? Browse open settlements →

What happened

Taro Pharmaceutical Industries Ltd. and individual defendants Michael Kalb and Kalyanasundaram Subramanian are settling claims that they violated securities laws. The settlement avoids continued litigation costs and risks by paying $36 million to eligible investors. The defendants are not admitting to any wrongdoing as part of this settlement.

Do you qualify?

Anyone who purchased Taro common stock on the open market on a United States stock exchange from July 2, 2014 through November 3, 2016 (inclusive) and was damaged thereby. Mutual fund investments do not qualify unless you personally purchased the stock during this period.

How to file

Submit a Claim Form to the Claims Administrator at JND Legal Administration (P.O. Box 91388, Seattle, WA 98111, or call 855-208-4121) by August 16, 2024. The form requires documentation of your Taro stock purchases during the class period. Note: the claim deadline has passed, and distributions were completed on December 23, 2025.

This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.

More securities settlements

View all →